The promise and challenges of personalized medicine for eye diseases

Clinical and Experimental Ophthalmology

Volumn 32, Issue 3, 2004, Pages 236-237

  McCarty, Catherine A ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DIABETIC RETINOPATHY; EDITORIAL; EYE DISEASE; FAMILY HISTORY; GENE IDENTIFICATION; GENE INTERACTION; GENE THERAPY; GENETIC COUNSELING; GENETIC SCREENING; GENOMICS; HEALTH CARE DELIVERY; HIGH RISK PATIENT; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; MYOPIA; OPEN ANGLE GLAUCOMA; PATIENT CARE; PROTEOMICS; RETINA MACULA AGE RELATED DEGENERATION; HEALTH SERVICE; METHODOLOGY; NOTE; PHARMACOGENETICS;

EYE DISEASES; HUMANS; PERSONAL HEALTH SERVICES; PHARMACOGENETICS;

EID: 3142592632     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2004.00833.x     Document Type: Editorial

References (6)

1. Gilmartin B. Myopia: precedents for research in the twenty-first century. Clin Experiment Ophthalmol 2004; 32: 305-24.
2. McNaught AI, Allen JG, Healey DL et al. Accuracy and implications of a reported family history of glaucoma: experience from the Glaucoma Inheritance Study in Tasmania. Arch Ophthalmol 2000; 118: 900-4.
3. Khoury MJ. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 2003; 5: 261-8.
4. Damji KF, Allingham RR. Molecular genetics is revolutionizing our understanding of ophthalmic disease. Am J Ophthalmol 1997; 124: 530-43.
5. Mackey DA, Craig JE. Predictive DNA testing for glaucoma: reality in 2003. Ophthalmol Clin North Am 2003; 16: 639-45.
6. Francis PJ, Stout JT. Gene therapy and control of angiogenesis. Ophthalmol Clin North Am 2003; 16: 575-82.